This review gives an overview of current screening practices for cervical cancer. In the
introduction, we will cover approaches of population screening focusing on high-risk Human …

Cervical cancer, a potentially preventable disease, remains the second most common
malignancy in women worldwide. Human papillomavirus (HPV) is the single most important …

Introduction: High-risk human papillomavirus (hrHPV) testing is expected to replace cytology
as primary screening method for cervical cancer screening in an increasing number of …

Since the Pap test was introduced in the 1940s, there has been an approximately 70%
reduction in the incidence of squamous cell cervical cancers in many developed countries …

Human papillomaviruses (HPVs) cause cervical lesions, which can, in some instances,
progress to high-grade neoplasia and cancer. Around half a million cases of cervical cancer …

Introduction: The HPV virus accounts for the majority of cervical cancer cases. Although a
diagnostic tool (Pap Test) is widely available, cervical cancer incidence still remains high …

In industrialized countries, population wide cytological screening programs using the Pap
test have led to a substantial reduction of the incidence of cervical cancer. Despite this …

Introduction: It is expected that in the near future high-risk human papillomavirus (hr-HPV)
testing will be implemented as the primary cervical cancer screening method in some …

Introduction Cervical cancer affects half a million women worldwide annually. Given the
association between high-risk human papillomavirus (hrHPV) infection and carcinogenesis …

Excellent recommendations exist for studying therapeutic and diagnostic questions. We
observe that good guidelines on assessment of evidence for screening questions are …